Elisa Sicuri PhD

Elisa Sicuri holds a PhD in Economics from the University of Pavia (Italy). In addition to her position as Associate Research Professor at the Barcelona Institute for Global Health (ISGlobal) and as Associate Professor at the University of Barcelona, she holds a part-time research position at the Department of Health Policy, London School of Economics and Political Science. Elisa is also associated researcher at the Centre d’économie of the Sorbonne University. From 2015 to 2020 she was a Research Fellow at the Department of Infectious disease epidemiology, Imperial College London.

Elisa works on health economics in low- and middle-income countries. Her research focuses on the economics of infectious diseases, particularly of neglected tropical diseases/vector-borne diseases, and includes a range of studies: cost-effectiveness/cost-benefit analysis of health interventions, analysis of the market for health products and impact evaluation of infectious diseases (interventions) on economic indicators.

She is currently leading the economic workstream of a number of large projects, including “Vaccine for prevention and treatment of Trypanosoma cruzi infection (CRUZIVAX)”, “Fast and reliable easy-to-use diagnostics for eliminating Bilharzia in young children and mothers (FreeBILy)” and “Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA)” among others. She is also contributing to the health economics workstreams of the studies “Prevention and management tools for reducing antibiotic resistance in high prevalence settings (REVERSE)”, “Indo-European Consortium for Next Generation Influenza Vaccine Innovation (INCENTIVE)” projects and “Phase 3 evaluation of innovative simple molecular test for the diagnosis of malaria in different endemic and health settings in Sub-Saharan Africa (DIAGMAL)”